摘要
肿瘤干细胞(CSCs)理论认为肿瘤的分化形式与正常细胞相似,致肿瘤性的类干细胞亚群能够产生更多分化的非致肿瘤的肿瘤细胞。CSCs具有化学药物抵抗性(抗药性),这个特点与肿瘤的复发和转移有密切关系。因此,研究CSCs有助于我们更好理解肿瘤的生物学特点,从而可以找出更为有效的抗肿瘤治疗新方法。现就肺CSCs在肺癌的诊断、治疗和预后方面的意义综述如下。
出处
《中华胸心血管外科杂志》
CSCD
北大核心
2011年第6期380-382,共3页
Chinese Journal of Thoracic and Cardiovascular Surgery
参考文献26
-
1Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells--perspec- tives on current status and Tools and targets to fight lung cancer A Eramo et al 4633 Oncogenefuture directions: AACR Workshop on cancer stem ceils. Cancer Res,2006,66:9339 -9344.
-
2Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 2008,15:504 - 514.
-
3Visvader JE, Lindeman GJ. Cancer stern cells in solid tumours :accu- mulating evidence and unresolved questions. Nat Rev Cancer,2008, 8:755 - 768.
-
4Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Ce11,2007,1:555 - 567.
-
5Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature,2004,432 : 396 -401.
-
6Beier D, Hau P, Proescholdt M, et al. CD133 ( + ) and CD133 ( - ) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res, 2007, 67: 4010 -4015.
-
7I OBrien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007,445:106 - 110.
-
8Todaro M, Alea MP, Di Stefano AB, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Ce11,2007,1:389 -402.
-
9Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA,2007, 104 : 10158 - 10163.
-
10Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells ( SC ) and tracks SC overpopulation during colon tumorigenesis. Cancer Res ,2009,69 : 3382 - 5389.
同被引文献34
-
1杜美蓉,李大金,王明雁,朱影,袁敏敏,孟毅.CD1332/AC141——一种滋养层细胞新的细胞内标志[J].生殖医学杂志,2004,13(6):360-364. 被引量:2
-
2Trerotola M, Rathore S, Goel HL, et al. CD 133, Trop-2 and α2131 integrin surface receptors as markers of putative hu- man prostate cancer stem cells [J]. Am J Transl Res, 2010,2(2) : 135-144.
-
3Taylor RA,Toivanen R,Risbridger GP,et al. Stem cells in prostate cancer:treating the root of the problem [J]. En- docr Relat Cancer, 2010,17(4) : 273-285.
-
4Kobayashi H, Minami Y, Anami Y, et al. Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma [J]. Virchows Arch, 2010,457 (1):69-76.
-
5Yin AH,Miraglia S,Zanjani ED,et al. AC133,a novel marker for human hematopoietic stem and progenitor cells [J]. Blood, 1997,90 (12) : 5002-5012.
-
6Eramo A, Lotti F, Sette G, et al. Identification and expan- sion of the tumorigenic lung cancer stem cell population [J]. Cell Death Differ,2008,15(3) :504-514.
-
7Coldren CD,Helfrich BA,Witta SE,et al. Baseline gene expression predicts sensitivity to gefitinib in nonsmall cell lung cancer cell lines [J]. Mol Cancer Res,2006,4(8) : 521-528.
-
8Wang J, Day R, Dong Y, et al. Identification of TROP-2 as an oncogene and an attractive therapeutic target in colon cancers [ J ]. Mol Cancer Ther, 2008,7 ( 2 ) : 280-285.
-
9Muhlmann G,Spizzo G,Gostner J,et al. TROP2 expres- sion as prognostic marker for gastric carcinoma[J]. J Clin Pathol, 2009,62 (2) : 152-158.
-
10Neagu M, Constantin C,Tanase C, et al. Patented biomark- er panels in early detection of cancer [J]. Recent Patents on Biomarkers, 2011,1 (1) : 10-24.
引证文献3
-
1顾宇平,朱一蓓,张光波,赵云根,黄建安.CD133、TROP-2在非小细胞肺癌中的表达及相关性研究初探[J].南京医科大学学报(自然科学版),2012,32(10):1396-1400. 被引量:2
-
2宋仕茂,何晓文.CD133及CD44在非小细胞肺癌中的表达及意义[J].现代肿瘤医学,2014,22(6):1318-1320. 被引量:6
-
3蔡传书,王培荣,黄雄,吕文龙.5种肿瘤干细胞标志物在非小细胞肺癌组织中的表达及临床意义[J].中国老年学杂志,2016,36(23):5905-5907. 被引量:6
二级引证文献13
-
1李丹,江露,徐斌,蒋敬庭,李翀.CD133在非小细胞肺癌中的表达及预后意义的Meta分析[J].临床肿瘤学杂志,2013,18(10):898-904.
-
2吴磊,惠慧,董楠,周云松,樊利妮,王浩.沉默CD44表达对乳腺癌细胞MDA-MB-231增殖与侵袭的影响[J].现代肿瘤医学,2015,23(14):1967-1970. 被引量:11
-
3都瑾,高建辉,韩纪昌,李红兵,程相树.非小细胞肺癌肿瘤组织干细胞标志物CD133的表达[J].中国组织工程研究,2015,19(36):5816-5820. 被引量:5
-
4高世乐,胡宗涛.血管内皮生长因子和黏附分子蛋白CD44变异体6与非小细胞肺癌同步放化疗近期疗效的相关性[J].中国医药,2017,12(10):1507-1510. 被引量:9
-
5段瑞,李永生,夏翼超.特异性干扰TACC3基因表达对CD133^+CD44^+口腔鳞癌干细胞增殖及凋亡的影响[J].中国组织工程研究,2017,21(25):3997-4002. 被引量:5
-
6韩丽丽.肺腺癌中RNPC1蛋白、EGFRv Ⅲ蛋白表达水平及意义[J].临床肺科杂志,2019,24(7):1278-1281. 被引量:2
-
7唐治蓉,龙琼先,刘欣雅,廖文华,张旭乾.CD133及CD44在肺癌组织中表达及其与临床病理学特征和预后的关系[J].中国实验诊断学,2019,23(12):2108-2112. 被引量:10
-
8黄小龙,万姗.双靶向吉非替尼磷脂胶束纳米载体靶向肺癌干细胞和肺癌细胞研究[J].临床肺科杂志,2020,25(2):172-176.
-
9马妮萨.血清PTX3、肺癌组织中LOXL2蛋白表达与NSCLC患者预后的关系[J].实验与检验医学,2020,38(1):187-189. 被引量:4
-
10刘振峰,刘代顺,周国旗,李云飞,李廷超.CD44与IFITM3在非小细胞肺癌中的表达及应用价值[J].中国老年学杂志,2021,41(22):4914-4917. 被引量:2
-
1Xiaoyan Li Zehua Wang.Expression of cyclooxygenase-2 mRNA in drug-sensitive cell and drug-resistant strains of ovarian cancer cell lines[J].Journal of Nanjing Medical University,2006,20(1):52-54.
-
2邵贤,陈钟.ErbB3分子标志物在肿瘤靶向治疗中的研究进展[J].南通大学学报(医学版),2016,36(2):133-138.
-
3孙晓峰,冼美生.大肠癌细胞DNA含量、增殖活性与病理形态学及预后的关系[J].癌症,1989,8(4):255-258. 被引量:1
-
4孟灵梅,周丽雅,李渊,丁士刚,金珠,崔荣丽,张贺军.青年胃癌患者的临床特点分析[J].中国微创外科杂志,2017,17(1):46-50. 被引量:12
-
5肿瘤病理学、病因学[J].国外科技资料目录(医药卫生),1997(10):108-110.
-
6Charles G. Eberhart.髓母细胞瘤干细胞[J].中国神经肿瘤杂志,2009,7(4):301-310.
-
7张腾飞,陈诗书.细胞因子基因转导的人肿瘤细胞免疫原性及致瘤性研究[J].上海免疫学杂志,1996,16(1):1-4. 被引量:10
-
8于学宽,郭小红,赵刚,曾嘉,沈伟,杨海贤,白景文.小鼠乳腺癌化疗后残留癌细胞的形态学研究[J].天津医药,2001,29(10):616-617.
-
9张宏,冼美生,孙晓峰,袁玖.食管鳞癌血型抗原变化,DNA含量改变与病理形态学的关系[J].肿瘤防治研究,1989,16(4):193-196.
-
10刘斌,卢放根.胃良恶性病变组织中PTEN mRNA和p73mRNA表达及意义[J].中南大学学报(医学版),2005,30(4):481-482. 被引量:1